Kobayashi Pharmaceutical Co Ltd

Common Name

Kobayashi Pharmaceutical

Country

Japan

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

3,615

Ticker

4967

Exchange

TOKYO STOCK EXCHANGE

Website

www.kobayashi.co.jp

Description

Kobayashi Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in developing, manufacturing, and selling consumer health products. The company's portfolio includ... Show more

Financial Statements of Kobayashi Pharmaceutical

Below are the financial statements of Kobayashi Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of JPY	2024	2023
Net sales	165,600^a	173,455^a
Cost of sales	-77,997^a	-77,079^a
Gross profit	87,603^a	96,375^a
Selling, general and administrative expenses	—	—
Sales promotion expenses	-3,435^a	-3,690^a
Freight and storage	-5,294^a	-4,704^a
Advertising expenses	-8,140^a	-19,348^a
Salaries, allowances and bonuses	-16,289^a	-14,849^a
Retirement benefit expenses	-765^a	-887^a
Taxes and dues	-753^a	-930^a
Depreciation	-3,433^a	-2,076^a
Amortization of goodwill	-1,407^a	-1,128^a
Rent	-1,558^a	-1,521^a
Fees paid	-5,160^a	-5,419^a
Research and development expenses	-9,109^a	-9,004^a
Other	-7,391^a	-7,035^a
Selling, general and administrative expenses total	-62,742^a	-70,595^a
Operating income	24,860^a	25,780^a
Non-operating income	—	—
Interest income	207^a	214^a
Dividend income	608^a	548^a
Real estate rental income	300^a	295^a
Foreign exchange gain	330^a	40^a
Compensation income	347^a	451^a
Other	683^a	636^a
Non-operating income total	2,477^a	2,187^a
Non-operating expenses	—	—
Interest expense	-28^a	-29^a
Real estate rental cost	-106^a	-105^a
Provision for doubtful accounts	-151^a	-154^a
Other	-189^a	-347^a
Non-operating expenses total	-476^a	-637^a
Ordinary income	26,861^a	27,330^a
Extraordinary income	—	—
Gain on sale of fixed assets	21^a	11^a
Gain on sale of investment securities	635^a	436^a
Other	4^a	14^a
Extraordinary income total	662^a	461^a
Extraordinary losses	—	—
Loss on disposal of fixed assets	-72^a	-70^a
Product recall-related losses	-12,524^a	0^a
Other	-1,012^a	-161^a
Extraordinary losses total	-13,609^a	-232^a
Income before income taxes	13,914^a	27,559^a
Current income taxes	-5,240^a	-8,297^a
Deferred income taxes	-1,398^a	-1,076^a
Income taxes total	-3,842^a	-7,221^a
Net income	10,071^a	20,338^a
Net income attributable to noncontrolling interests	4^a	0^a
Net income attributable to owners of parent	10,067^a	20,338^a

Download Data

Verified Sources Behind Kobayashi Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kobayashi Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Kobayashi Pharmaceutical's Integrated Report 2025

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Kobayashi Pharmaceutical Co Ltd

Financial Statements of Kobayashi Pharmaceutical

Verified Sources Behind Kobayashi Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Rohto Pharmaceutical Co Ltd

Lion Corp

Unicharm Corp

NH Foods Ltd

Japan Tobacco Inc

Seven & i Holdings Co Ltd